Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade

Molecular Carcinogenesis

Volumn 51, Issue 2, 2012, Pages 139-149

  Kuc, Christian ^a   Jenkins, Audrey ^b   van Dross, Rukiyah T ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

Author keywords

Anandamide; Bioactive lipids; Cannabinoid; COX 2; Keratinocyte

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ACETYLCYSTEINE; ANANDAMIDE; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 2; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; RIMONABANT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TUMOR CELL;

AMIDOHYDROLASES; ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; BLOTTING, WESTERN; CELL LINE, TUMOR; IN SITU NICK-END LABELING; MICE; POLYUNSATURATED ALKAMIDES; PROSTAGLANDINS; RECEPTORS, CANNABINOID;

EID: 84855243235     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20770     Document Type: Article

References (41)

1. Oesch S, Gertsch J. 2009; Cannabinoid receptor ligands as potential anticancer agents - High hopes for new therapies? J Pharm Pharmacol 61: 839-853.
2. Montecucco F, Lenglet S, Braunersreuther V, et al. 2009; CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. J Mol Cell Cardiol 46: 612-620.
3. Martin WJ, Lai NK, Patrick SL, Tsou K, Walker JM. 1993; Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res 629: 300-304.
4. Di MV. 1998; 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392: 153-175.
5. Melck D, Rueda D, Galve-Roperh I, De PL, Guzman M, Di MV. 1999; Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 463: 235-240.
6. Gomez del PT, Velasco G, Guzman M. 2000; The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347: 369-373.
7. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K. 2008; GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105: 2699-2704.
8. Evans RM, Scott RH, Ross RA. 2004; Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 141: 1223-1233.
9. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. 1996; Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87.
10. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. 2000; Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 275: 31938-31945.
11. Pasquariello N, Catanzaro G, Marzano V, et al. 2009; Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis. J Biol Chem 284: 29413-29426.
12. Casanova ML, Blazquez C, Martinez-Palacio J, et al. 2003; Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111: 43-50.
13. Siegmund SV, Seki E, Osawa Y, Uchinami H, Cravatt BF, Schwabe RF. 2006; Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. J Biol Chem 281: 10431-10438.
14. Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, Di MV. 2004; A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J 18: 1606-1608.
15. DeMorrow S, Glaser S, Francis H, et al. 2007; Opposing actions of endocannabinoids on cholangiocarcinoma growth: Recruitment of Fas and Fas ligand to lipid rafts. J Biol Chem 282: 13098-13113.
16. Patsos HA, Greenhough A, Hicks DJ, et al. 2010; The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. Int J Oncol 37: 187-193.
17. Kozak KR, Crews BC, Morrow JD, et al. 2002; Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277: 44877-44885.
18. Yu M, Ives D, Ramesha CS. 1997; Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272: 21181-21186.
19. Van Dross RT. 2009; Metabolism of anandamide by COX-2 Is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. Mol Carcinog 48: 724-732.
20. Patsos HA, Hicks DJ, Dobson RR, et al. 2005; The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: A possible role for cyclooxygenase 2. Gut 54: 1741-1750.
21. Eichele K, Ramer R, Hinz B. 2009; R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. Pharm Res 26: 346-355.
22. Fukushima M, Kato T, Ota K, Arai Y, Narumiya S, Hayaishi O. 1982; 9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities. Biochem Biophys Res Commun 109: 626-633.
23. Uchida K, Shibata T. 2007; 15-Deoxy-delta(12, 14)-prostaglandin J2: An electrophilic trigger of cellular responses. Chem Res Toxicol 21: 138-144.
24. Cocca C, Dorado J, Calvo E, Lopez JA, Santos A, Perez-Castillo A. 2009; 15-Deoxi-Delta(12, 14)-prostaglandin J(2) is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest. Biochem Pharmacol 78: 1330-1339.
25. Chen YC, Shen SC, Tsai SH. 2005; Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. Biochim Biophys Acta 1743: 291-304.
26. Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, Rossi AG. 2002; Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol 168: 6232-6243.
27. Jemal A, Siegel R, Xu J, Ward E. 2010; Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
28. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. 2001; Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 276: 12076-12083.
29. Ishii T, Itoh K, Takahashi S, et al. 2000; Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029.
30. Weber A, Ni J, Ling KH, et al. 2004; Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J Lipid Res 45: 757-763.
31. McQuaid Kenneth R. 2010; Drugs Used in the Treatment of Gastrointestinal Diseases.
32. Health Canada Drug Product Database. 2010; Ref Type: Generic.
33. Woodward DF, Carling RW, Cornell CL, et al. 2008; The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther 120: 71-80.
34. Boekholdt SM, Peters RJ. 2010; Rimonabant: Obituary for a wonder drug. Lancet 376: 489-490.
35. Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K. 2004; Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol 66: 1643-1651.
36. Matias I, Chen J, De PL, et al. 2004; Prostaglandin ethanolamides (prostamides): In vitro pharmacology and metabolism. J Pharmacol Exp Ther 309: 745-757.
37. Ciucci A, Gianferretti P, Piva R, et al. 2006; Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: Role of the IkappaB kinase/nuclear factor-kappaB pathway. Mol Pharmacol 70: 1812-1821.
38. Clay CE, Namen AM, Atsumi G, et al. 1999; Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 20: 1905-1911.
39. Millan O, Rico D, Peinado H, et al. 2006; Potentiation of tumor formation by topical administration of 15-deoxy-delta12, 14-prostaglandin J2 in a model of skin carcinogenesis. Carcinogenesis 27: 328-336.
40. Levonen AL, Dickinson DA, Moellering DR, Mulcahy RT, Forman HJ, rley-Usmar VM. 2001; Biphasic effects of 15-deoxy-delta(12, 14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol 21: 1846-1851.
41. Schumacher MA, Eilers H. 2010; TRPV1 splice variants: Structure and function. Front Biosci 15: 872-882.